Evidence map›Paper›PMID 27247920›Full record

ArticleAvicenna journal of phytomedicine

Effects of Nigella sativa oil extract on inflammatory cytokine response and oxidative stress status in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled clinical trial.

Vahid Hadi, Sorayya Kheirouri, Mohammad Alizadeh, Alireza Khabbazi, Hossein Hosseini

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Avicenna journal of phytomedicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06560775 (Potential Effects of Nigella Sativa on T Lymphocytes and Inflammatory Cytokine Profile in Pediatric Systemic Lupus Erythematosus), which is not on this map. Cited by 61 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 5 pooled it
19.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06560775 nacompletednot on this map

Potential Effects of Nigella Sativa on T Lymphocytes and Inflammatory Cytokine Profile in Pediatric Systemic Lupus Erythematosus: A Randomized Controlled Trial

TypeinterventionalSponsorUniversity of BrawijayaRan2022 to 2023Enrolled32ConditionsSLE (Systemic Lupus)ArmsStandard Treatment for SLE
3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 5 syntheses or guidelines pooled it, 134 citations in OpenAlex.

  1. Pooled it
  2. Effect ofCurrent pharmaceutical biotechnology · 2024
    Pooled it
  3. Pooled it
  4. The Effectiveness of Herbal Medicines on Cyclic Mastalgia: A Systematic Review on Meta-analysis.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2022
    Pooled it
  5. Effect ofTheScientificWorldJournal · 2020
    Pooled it
  6. Effects ofNarra J · 2024
    Trial
  7. Trial
  8. Effect ofF1000Research · 2021
    Trial
  9. Antibacterial Activity and Molecular Docking Studies of Black Cumin (International journal of molecular sciences · 2026
    Article
  10. Foods (Basel, Switzerland) · 2026
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Investigation of the Immunomodulatory and Neuroprotective Properties ofInternational journal of molecular sciences · 2025
    Article
  17. Article
  18. Review
  19. Heliyon · 2024
    Article
  20. Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Vahid HadiDepartment of Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran.
Sorayya KheirouriDepartment of Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran.
Mohammad AlizadehDepartment of Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran.
Alireza KhabbaziDepartment of Internal Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Hossein HosseiniDepartment of Agriculture, Barij Essence Pharmaceutical Company , Kashan, Iran.
Tabriz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveNigella sativa is a medicinal plant that has long been used in traditional medicine for treating various conditions. Numerous animal studies provided evidences that the seed may elicit a broad anti-inflammatory/anti-oxidant activity. The aim of the present clinical trial was to evaluate anti-inflammatory and antioxidant properties of Nigella sativa oil in patients with rheumatoid arthritis (RA). MATERIALS AND

methodsForty-two patients with RA were assigned into two groups in this randomized, double blind, placebo-controlled clinical trial. Subjects in intervention group received two capsules, 500 mg each, of Nigella sativa oil, each day for 8 weeks. The other group consumed two capsules as placebo per day for the same period of time. Serum TNF-α, IL-10, and whole blood levels of oxidative stress parameters were measured at baseline and end of the trial.

resultsThe serum level of IL-10 was increased in the Nigella sativa group (p<0.01). Moreover, treatment with Nigella sativa led to significant reduction of serum MDA and NO compared with baseline (p<0.05). There were no significant differences in the TNF-α, SOD, catalase, and TAS values between or within the groups, before and after the intervention (p>0.05).

conclusionThis study indicates that Nigella sativa could improve inflammation and reduce oxidative stress in patients with RA. It is suggested that Nigella sativa may be a beneficial adjunct therapy in this population of patients.

Indexed as

IL-10Nigella sativaOxidative stressRheumatoid arthritisTNF-α

Identifiers

PMID27247920
PMCPMC4884216
OpenAlexW1567703077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.